Maspin and mammaglobin genes are specific markers for RT-PCR detection of minimal residual disease in patients with breast cancer

Annals of Oncology

Volumn 12, Issue 12, 2001, Pages 1693-1698

  Corradini, P ^a,b   Voena, C ^a   Astolfi, M ^c   Dell'Oro, S ^b   Pilotti, S ^d   Arrigoni, G ^b   Bregni, M ^a   Pileri, A ^c   Gianni, A M ^b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

^d NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Breast cancer; Mammaglobin; Maspin; Residual disease

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 19; CYTOKERATIN 20; EPIDERMAL GROWTH FACTOR RECEPTOR; MAMMAGLOBIN; MASPIN; MUCIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; BLOOD CELL; BONE MARROW CELL; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; HUMAN CELL; MARKER GENE; MINIMAL RESIDUAL DISEASE; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TREATMENT PLANNING;

BREAST NEOPLASMS; CA-15-3 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CARCINOMA, DUCTAL, BREAST; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; KERATINS; NEOPLASM PROTEINS; NEOPLASM STAGING; NEOPLASM, RESIDUAL; NEOPLASMS, DUCTAL, LOBULAR, AND MEDULLARY; PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; SERPINS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; UTEROGLOBIN;

EID: 0035702477     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1013573108945     Document Type: Article

References (30)

1. A Prospective, randomized comparison of combination alkylating agents as consolidation after CAF in high-risk primary breast cancer involving ten or more axillary lymph nodes: Preliminary results of CALGB 9082/SWOG9114/NCIC MA-13
2. Phase III randomized trial of high-dose chemotherapy and stem cell support shows no difference in overall survival or severe toxicity compared to maintenance chemotherapy with cyclophosphamide, methotrexate with metastatic breast cancer who are responding to conventional induction chemotherapy: The 'Philadelphia' Intergroup Study (PBT-1)
3. High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer
4. A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy
5. Efficacy, toxicity, and applicability of high-dose sequential chemotherapy as adjuvant treatment in operable breast cancer with ten or more involved axillary nodes: Five-year results
6. Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometasases
7. Detection of tumor cells in bone marrow of patients with primary breast cancer: A prognostic factor for distant metastasis
8. Immunoistochemical distinction of human carcinomas by cytokeratins typing with monoclonal antibodies
9. Detection of tumor cells in the bone marrow, peripheral blood, and apheresis products of breast cancer patients using flow cytometry
10. Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer
11. Keratin 19 mRNA measurement to detect micrometastases in lymph nodes in breast cancer patients
12. Detection of cancer micrometastases in lymph nodes by reverse transcriptase polymerase chain reaction
13. Sensitive detection of occult breast cancer by reverse-transcriptase polymerase chain reaction
14. Detection of breast cancer micrometastases in axillary lymph nodes by means of reverse transcriptase polymerase chain reaction. Comparison between MUC1 mRNA and keratin 19 mRNA amplification
15. Detection of epithelial cancer cells in peripheral blood by reverse trancriptase-polymerase chain reaction
16. Limitations of specific reverse transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients
17. Sensitive detection of circulating breast cancer cells by reverse-transcriptase polymerase chain reaction of mas pin gene
18. Identification of superior markers for polymerase chain reaction detection of breast cancer metastases in sentinel lymph nodes
19. Clinical significance of molecular detection of carcinoma cells in lymph nodes and peripheral blood by reverse transcription-polymerase chain reaction in patients with gastrointestinal or breast carcinomas
20. Specific detection of carcinoembyonic antigen expressing tumor cells in bone marrow aspirates by polymerase chain reaction
21. Reverse trancriptase-polymerase chain reaction (RT-PCR)-controlled immunomagnetic purging of breast cancer cells using the magnetic cell separation (MACS) system: A sensitive method for monitoring purging efficiency
22. Mammaglobin, a mammary-specific member of uteroglobin gene family, is overexpressed in human breast cancer
23. Detection of circulating mammary carcinoma cells in the peripheral blood of breast cancer patients via a nested reverse transcriptase polymerase reaction assay for mammaglobin mRNA
24. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
25. Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors
26. Characterization and molecular cloning of a novel MUC1 protein, devoid of tandem repeats, expressed in human breast cancer tissue
27. Detection of circulating tumor cells by reverse transcriptase polymerase chain reaction of maspin in patients with breast cancer undergoing conventional-dose chemotherapy
28. Gene-marking to trace origin of relapse after autologous bone-marrow transplantation
29. Use of reverse-transcriptase polymerase chain reaction (RT-PCR) for carcinoembyonic antigen, cytokeratin 19, and maspin in the detection of tumor cells leukapheresis products from patients with breast cancer: Immunochemistry
30. Detection of micrometastases in colorectal cancer patients by K19 and K20 reverse trancriptions polymerase chain reaction